Skip to main content
Equibles

UBS Group AG

Position in CNSY — Cerenome, Inc.

CIK 1610520 ZURICH, V8
Back to CNSY Full portfolio

Position in CNSY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,053
+$2,053 QoQ
Shares Held
470
-99.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 22 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNSY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. CNSY ranks #498 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in CNSY

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,053 470
2026-03-31 — 87,850
2025-12-31 — 875,846
2025-09-30 — 623,874
2025-06-30 — 87,638
2025-03-31 — 33,437
2024-06-30 — 3,199
2023-12-31 — 8,899
2023-09-30 — 5,149
2023-03-31 — 13
2022-12-31 — 19,003
2022-09-30 — 16,208
2022-06-30 — 13,688
2022-03-31 — 13
2021-12-31 — 13
2021-09-30 — 13
2021-06-30 — 13
2021-03-31 — 13
2020-12-31 — 13
2020-09-30 — 13